×

Biotech and Pharmaceuticals Medicine

  • LONDON, Feb 24- A small study in 16 people with severe anorexia has found that implanting stimulation electrodes into the brains of patients could ease their anxiety and help them gain weight. Researchers found that in extreme cases of the eating disorder, the technique- known as deep brain stimulation- swiftly helped many of those studied reduce symptoms of...

  • *Positive results for Relvar Ellipta lung function study in patients with well-controlled asthma. *Patients randomised to FF/VI taken once-daily maintained lung function versus those randomised to twice-daily FP/SAL, meeting study's primary endpoint. *GSK now intends to submit this data to European Medicines Agency.

  • "It has been hard for us to keep up, with lots of folks running backup for each other," says Brandon Dudley, vice president of the Chicago- based company that arranges bus charters for events ranging from nights on the town to long-distance trips. In its latest report, the U.S. Centers for Disease Control and Prevention said 35 states had moderate to high levels of flu...

  • Feb 22- Argos Therapeutics Inc said on Wednesday that an independent data monitoring committee has recommended the company to discontinue its late-stage trial for the treatment of metastatic renal cell carcinoma.

  • The poor levels of life expectancy in the U.S. against other rich nations has been laid bare in a new report.

  • The researchers said more studies are needed to determine long-term effects— the kind of research the U.S. Food and Drug Administration has already asked supplement makers to conduct. "I don't think anybody would interpret these results as saying,' Wow, this is a fountain of youth, this is a magical anti-aging potion,'" said study co-author Susan Ellenberg, a...

  • Feb 21- Amphastar Pharmaceuticals Inc said on Tuesday that the U.S. Food and Drug Administration had rejected its application to market an intranasal version of the emergency opioid-overdose treatment, naloxone. The Centers for Disease Control and Prevention estimates that 91 Americans die every day from opioid overdoses. Amphastar already sells...

  • savings retirement

    A proposal from two Republican senators would create a Roth health savings account as part of a plan to replace the Affordable Care Act.

  • A flu shot being administered in Concord, California.

    This year's flu vaccine isn't quite as good as last year's formula, according to the CDC. NBC News reports.

  • SHANGHAI, Feb 17- Four years ago, a bird flu outbreak in China killed at least three dozen people, triggered mass poultry culling, put masks on millions of Chinese faces and hammered shares in fast food and travel companies. The number of posts mentioning "bird flu" or "H7N9" on China's popular Sina Weibo microblog- a useful proxy for gauging consumer interest or...

  • The drugmaker's shares were up 2.37 percent at 4,554 pence on the London Stock Exchange, while its U.S.-listed shares were up 1.70 percent at $29.25 in premarket trading on Friday. Lynparza, which won U.S. approval for ovarian cancer in 2014 and generated 2016 sales of $218 million, is one of the drugs that the drugmaker hopes will help achieve its target of more...

  • *With H7N9 strain, poultry show few symptoms. *Over 100 people have died from bird flu in China this winter. BEIJING, Feb 17- Bird flu infection rates on Chinese poultry farms may be far higher than previously thought, because the strain of the deadly virus that has killed more than 100 people this winter is hard to detect in chickens and geese, animal health experts say.

  • Chief Executive Flemming Ornskov said Shire had delivered record product sales and earnings in a year when it bought hemophilia drugs company Baxalta for $32 billion and launched a new medicine for dry eye disease. Total product sales would rise to $14.5- 14.8 billion this year, up from $10.9 billion, Shire said, and earnings per share would rise to $14.60- $15.20.

  • Soliris, approved for rare blood disorders paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, generated quarterly sales of $749 million, underwhelming consensus estimates of $756 million, according to Barclays. The New Haven, Connecticut- based company forecast 2017 adjusted earnings of $5.00- $5.25 per share and revenue of...

  • This scanning electron micrograph depicts a number of Leptospira sp. bacteria.

    The three cases occurred in the past two months in a Bronx neighborhood. City officials say it's the first time a cluster of cases has been identified.

  • Bioverative's hemophilia hopes

    CNBC's Meg Tirrell speaks with John Cox, Bioverativ CEO, about the company's spinoff from Biogen, its new innovations in treating hemophilia.

  • LONDON, Feb 15- Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan likely to hit the market imminently followed by a rival to its breast cancer medicine Herceptin. Approval from the pan-European regulator, the European Medicines Agency, is pending and preparations are...

  • Doctor and senior patient

    By 2030, 70 percent of HIV patients will be over 50. Now success of HIV drugs poses a new challenge: treating it as a geriatric condition.

  • LONDON, Feb 14- Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results for an experimental HIV drug that works in the same way as the British group's successful dolutegravir. Gilead's bictegravir, another so-called integrase inhibitor drug, delivered 97 percent virus suppression, making it just as effective as GSK's...

  • BRIEF-GSK ANNOUNCES POSITIVE FINAL STAGE RESULTS FOR TWO-DRUG. *VIIV phase III results dolutegravir& rilpivirine. *Headline results were announced in December 2016.